Authors: Mathias Maagaard, MD et al Anesthesiology March 2023. Background We hypothesized that both perineural and systemic dexamethasone as adjuncts to bupivacaine increase the duration of an ulnar nerve block compared with bupivacaine alone, and that systemic dexamethasone is non-inferior to perineural dexamethasone. Methods We performed bilateral ulnar nerve blocks with 3 ml bupivacaine 5 […]
Read MoreAuthor: Avery Hurt Practical Pain Management March 2023 The device’s dual-use approval opens up new options for migraine care in adolescents and adults. The FDA has approved Nerivio as a preventive treatment for migraine, with or without aura, in adults and children 12 years old and older, according to a February 28, 2023, press release from […]
Read MoreAuthor: Riz Hatton Becker’s ASC Review Here are eight anesthesia updates reported on March 3: 1. There are 42,264 total active anesthesiologists in the country, according to the Association of American Medical College’s “2022 Physician Specialty Data Report.” 2. New York City-based Columbia University is the most expensive top-ranked medical university for anesthesiologists in 2023, costing students $66,816 a […]
Read MoreAuthors: Jamie W. Sleigh, M.D.; Rebecca M. Pullon, Ph.D. Anesthesiology March 2023. To the Editor: We wish to report on a serendipitous technical observation regarding the calculation of the Granger causality between electroencephalogram (EEG) channels in subjects given propofol, as reported by Pullon et al. From subsequent application of this analysis to a separate patient dataset in […]
Read MoreAuthors: Hao Xiao, M.S. et al Anesthesiology April 2023, Vol. 138, 364–371. Background Chlorhexidine generally has a good safety profile. However, allergic reactions are reported with increasing frequency. In China, it is rarely reported, and its characteristics are unknown. The purpose of this study was to summarize the experience of a Chinese allergy center with chlorhexidine […]
Read More